approved EB-2 (NIW)

Physician

Cancer Medicine · 2026-01-17

Processing Time
46 days
Decision Date
2026-01-17
Location
U.S.-based healthcare environment
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to collect and analyze data from cancer research studies to assess the efficacy and complications of cancer therapies. This work aims to strengthen evidence-based treatment decisions and improve real-world outcomes for patients by characterizing adverse effects that may compromise quality of life.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses national-scale healthcare needs by improving cancer therapy safety and patient outcomes.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned through a record of over 10 publications and 400 citations, indicating their work is a foundation for other researchers.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's contributions to clinical medicine and cancer research justify the waiver of the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on more than 10 peer-reviewed journal articles and over 400 citations, with multiple papers ranking in the top 10% of their publication years. The record demonstrated that the petitioner's work is meaningfully relied upon in clinical medicine and addresses national-scale healthcare needs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Original Contributions

Similar Cases

Software Engineer

Artificial Intelligence · India

WeGreened EB-2 (NIW) approved
California 111 days 2026-12-13
The petitioner proposes to develop AI-driven activity monitoring methods for quality assurance in large-scale digital systems. The work focuses on identifying risks earlier and improving reliability to reduce costly disruptions across complex software platforms.

Management Consultant

Information Technology

WeGreened EB-2 (NIW) approved
2026-03-15
The petitioner proposes to continue their work in enterprise technology transformation, governance, and large-scale operational strategy. The work focuses on enhancing enterprise resilience, cybersecurity alignment, and digital transformation within major organizations to improve high-stakes operational settings.

Researcher

Healthcare

WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.

Others

Information Technology · China

WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2026-01-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 46 days
Criteria Met 3 / 3
Evidence Types 3

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist